Institutional investors purchased a net $1.1 million shares of ALIM during the quarter ended June 2016 and now own 52.39% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
J. GOLDMAN & CO. LP Bought 1.8 Million shares of Alimera Sciences Inc
GREAT POINT PARTNERS LLC Bought 776.3 Thousand shares of Alimera Sciences Inc